New: A brand-new, unused, unopened, undamaged item in its original packaging (where packaging is
applicable). Packaging should be the same as what is found in a retail store, unless the item is handmade or was packaged by the manufacturer in non-retail packaging, such as an unprinted box or plastic bag. See the seller's listing for full details.
See all condition definitions
Staples One-Touch 884279 Black Capacity 30-Sheet Punch 3-Hole Heavy-Duty 26614 Other Office Desk Accessories
gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,
Staples One-Touch 884279 Black Capacity 30-Sheet Punch 3-Hole Heavy-Duty 26614 Other Office Desk Accessories
lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,
sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,
Heart Shape Mystic & White Topaz 925 Sterling Silver Engagement Ring
8N11450-12V 3 Post 12 Volt Starter Solenoid For Ford Tractor 2N 8N 9N Tractors
, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.
